Evaluation of HPV type-replacement in unvaccinated and vaccinated adolescent females-Post-hoc analysis of a community-randomized clinical trial (II)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evaluation of HPV type-replacement in unvaccinated and vaccinated adolescent females-Post-hoc analysis of a community-randomized clinical trial (II)

Published:2018-02-12 Issue:12 Volume:142 Page:2491-2500
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Gray Penelope¹,Palmroth Johanna¹,Luostarinen Tapio²,Apter Dan³,Dubin Gary⁴,Garnett Geoff⁵,Eriksson Tiina¹,Natunen Kari¹,Merikukka Marko⁶,Pimenoff Ville¹⁷,Söderlund-Strand Anna⁸,Vänskä Simopekka²⁶,Paavonen Jorma⁹,Pukkala Eero¹,Dillner Joakim²,Lehtinen Matti¹²^ORCID

Affiliation:

1. Faculty of Social Sciences; University of Tampere; Tampere Finland

2. Department of Laboratory Medicine; Karolinska Institute; Stockholm Sweden

3. VL Medi; Helsinki Finland

4. Takeda Pharmaceuticals International; Switzerland

5. Gates Foundation; Seattle WA

6. Department of Vaccines; Institute for Health and Welfare; Laskut Finland

7. Catalan Institute of Oncology, IDIBELL; Barcelona Spain

8. Department of Clinical Microbiology; Skåne University Hospital; Lund Sweden

9. Department of Obstetrics and Gynaecology; University of Helsinki; Helsinki Finland

Funder

Academy of Finland

Finnish Cancer Organizations

EU FP7 networks PREHDICT and CoheaHR

GlaxoSmithKline Biologicals SA

Terveyden Tutkimuksen Toimikunta

FP7 Health

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ijc.31281/fullpdf

Reference36 articles.

1. Clinical trials of human papillomavirus vaccines and beyond;Lehtinen;Nat Rev Clin Oncol,2013

2. A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women;Joura;N Engl J Med,2015

3. The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years;Brown;J Infect Dis,2009

4. Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial;Wheeler;Lancet Oncol,2012

5. A randomized, observer-blinded immunogenicity trial of Cervarix(®) and Gardasil(®) human papillomavirus vaccines in 12-15 year old girls;Draper;PLos One,2013

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pattern of multiple human papillomavirus infection and type competition: An analysis in healthy Chinese women aged 18–45 years;Human Vaccines & Immunotherapeutics;2024-04-15

2. Ecological diversity profiles of non-vaccine-targeted HPVs after gender-based community vaccination efforts;Cell Host & Microbe;2023-11

3. High Prevalence of HPV 51 in an Unvaccinated Population and Implications for HPV Vaccines;Vaccines;2022-10-20

4. Evolution of human papilloma virus prevalence in a highly vaccinated region in Belgium: a retrospective cohort study in Flemish women (2010–2019);European Journal of Cancer Prevention;2022-05-25

5. Reduction in Vaccine HPV Type Infections in a Young Women Group (18–25 Years) Five Years after HPV Vaccine Introduction in Colombia;Cancer Prevention Research;2021-10-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3